as well as other risks and uncertainties set forth in Trevi's quarterly report on Form 10-Q for the quarter ended September 30, 2024 filed with the Securities and Exchange Commission and in subsequent ...
NEW HAVEN, CT – Trevi Therapeutics, Inc. (NASDAQ:TRVI), whose shares have surged over 110% year-to-date according to InvestingPro data, announced today positive outcomes from its human abuse potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback